Holen Sie sich die Stockscreener-App
3.085
3.18%
0.095
Handel nachbörslich:
3.09
0.005
+0.16%
Schlusskurs vom Vortag:
$2.99
Offen:
$3
24-Stunden-Volumen:
1.53M
Relative Volume:
0.43
Marktkapitalisierung:
$416.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-5.4123
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
+4.22%
1M Leistung:
+24.40%
6M Leistung:
+316.89%
1J Leistung:
+76.29%
1-Tages-Spanne:
$2.88
$3.18
1-Wochen-Bereich:
$2.77
$3.47
52-Wochen-Spanne:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Vergleichen Sie PROK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
3.085 | 403.63M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
Why ProKidney Corp. is moving today2025 Macro Impact & Weekly Momentum Stock Picks - newser.com
Heatmap analysis for ProKidney Corp. and competitorsMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
Using AI based signals to follow ProKidney Corp.July 2025 Breakouts & Weekly High Return Opportunities - newser.com
Is ProKidney Corp. stock poised for growthBond Market & Technical Pattern Alert System - newser.com
How to monitor ProKidney Corp. with trend dashboardsQuarterly Profit Report & Safe Capital Preservation Plans - newser.com
Short interest data insights for ProKidney Corp.Layoff News & Community Consensus Stock Picks - newser.com
Price momentum metrics for ProKidney Corp. explainedWeekly Profit Summary & Consistent Income Trade Ideas - newser.com
Risk adjusted return profile for ProKidney Corp. analyzed2025 Sector Review & Smart Investment Allocation Insights - newser.com
Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks - simplywall.st
ProKidney's (PROK) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Why ProKidney Corp. stock appeals to dividend seekersJuly 2025 Earnings & Weekly Top Gainers Trade List - newser.com
Real time pattern detection on ProKidney Corp. stock2025 Winners & Losers & Fast Exit and Entry Strategy Plans - newser.com
ProKidney (NASDAQ:PROK) Shares Gap DownWhat's Next? - MarketBeat
Will ASN Spotlight On REGEN-007 Propel ProKidney Toward Accelerated Approval? - RTTNews
What institutional flow reveals about ProKidney Corp.Layoff News & Smart Allocation Stock Reports - newser.com
Smart tools for monitoring ProKidney Corp.’s price actionGap Up & Community Consensus Trade Alerts - newser.com
ProKidney Corp (PROK) Touts Reparencel Therapy for Growth - MSN
Will ProKidney Corp. see short term momentumJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
Is it time to cut losses on ProKidney Corp.2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
ProKidney (NASDAQ:PROK) Trading 8.1% HigherShould You Buy? - MarketBeat
What drives ProKidney Corp stock priceTop Performing Stocks & Create Your Free Watchlist Instantly - earlytimes.in
Is ProKidney Corp a good long term investmentRisk Management Strategies & Low Cost Market Strategies - earlytimes.in
ProKidney Corp. (NASDAQ:PROK) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Layoff Watch: Is TBBB stock a top performer YTDGDP Growth & Weekly High Momentum Picks - khodrobank.com
ProKidney spikes after mid-stage trial data for lead asset - MSN
Earnings Beat: Is ProKidney Corp impacted by rising ratesWeekly Gains Report & Stepwise Trade Execution Plans - khodrobank.com
Whale Trades: What are ProKidney Corp.’s recent SEC filings showingGlobal Markets & Verified Entry Point Detection - خودرو بانک
ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy - Seeking Alpha
ETF Watch: Why is ProKidney Corp stock going downJuly 2025 Review & Community Driven Trade Alerts - خودرو بانک
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):